Unlock stock picks and a broker-level newsfeed that powers Wall Street.
ASX - Delayed Quote AUD

Singular Health Group Ltd (SHG.AX)

Compare
0.2250
-0.0050
(-2.17%)
At close: April 4 at 4:10:37 PM GMT+11
Loading Chart for SHG.AX
  • Previous Close 0.2300
  • Open 0.2300
  • Bid 0.2200 x --
  • Ask 0.2300 x --
  • Day's Range 0.2200 - 0.2300
  • 52 Week Range 0.0740 - 0.3000
  • Volume 464,883
  • Avg. Volume 697,883
  • Market Cap (intraday) 59.806M
  • Beta (5Y Monthly) -0.28
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Singular Health Group Ltd, a medical technology company, engages in the development and commercialization of volumetric rendering platform (VRP) and software development in Australia. The company offers 3Dicom Viewer, a cross-platform application that allows its users to interact with standard 2D medical images, such as MRI and CT scans in 3D; 3DicomVSP, a virtual surgical planning platform; Health Academy, a scalable multi-lingual platform that provides templated curriculum aligned lessons; and GeoVR, a cloud platform for use in the mineral resources sector. Singular Health Group Ltd was incorporated in 2020 and is headquartered in Bibra Lake, Australia.

singular.health

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: SHG.AX

View More

Performance Overview: SHG.AX

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

SHG.AX
0.00%
S&P/ASX 200 [XJO] (^AXJO)
6.02%

1-Year Return

SHG.AX
95.65%
S&P/ASX 200 [XJO] (^AXJO)
1.36%

3-Year Return

SHG.AX
8.43%
S&P/ASX 200 [XJO] (^AXJO)
2.05%

5-Year Return

SHG.AX
35.71%
S&P/ASX 200 [XJO] (^AXJO)
51.31%

Compare To: SHG.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SHG.AX

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    59.81M

  • Enterprise Value

    58.57M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    12.46

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -57.32%

  • Return on Equity (ttm)

    -162.51%

  • Revenue (ttm)

    877.95k

  • Net Income Avi to Common (ttm)

    -3.86M

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.63M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.07M

Research Analysis: SHG.AX

View More

Company Insights: SHG.AX

Research Reports: SHG.AX

View More

People Also Watch